Abhijit Duggal

Dr. Abhijit Duggal

Intensive Care Medicine
8950 Euclid Ave, 
Cleveland, OH 
8950 Euclid Ave, 
Cleveland, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Abhijit Duggal is an Intensive Care Medicine provider in Cleveland, Ohio. Dr. Duggal is rated as an Experienced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Venous Thromboembolism (VTE), Pulmonary Fibrosis, Liver Failure, End-Stage Renal Disease (ESRD), and Endoscopy.

His clinical research consists of co-authoring 240 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Residency
Western Reserve Care System
Specialties
Intensive Care Medicine
Licenses
Critical Care Medicine in OH
Board Certifications
American Board Of Internal Medicine, 2012
Fellowships
University of Toronto Hospitals
Hospital Affiliations
Cleveland Clinic
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

CLEVELAND CLINIC
8950 Euclid Ave, Cleveland, OH 44195
Other Locations
CLEVELAND CLINIC
9500 Euclid Ave, Cleveland, OH 44195

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

CONNECTS Master Protocol for Clinical Trials Targeting Macro-, Micro-immuno-thrombosis, Vascular Hyperinflammation, and Hypercoagulability and Renin-angiotensin-aldosterone System (RAAS) in Hospitalized Patients With COVID-19 (ACTIV-4 Host Tissue)
CONNECTS Master Protocol for Clinical Trials Targeting Macro-, Micro-immuno-thrombosis, Vascular Hyperinflammation, and Hypercoagulability and Renin-angiotensin-aldosterone System (RAAS) in Hospitalized Patients With COVID-19 (ACTIV-4 Host Tissue)
Enrollment Status: Completed
Publish Date: January 22, 2025
Intervention Type: Drug
Study Drugs: TXA127, TRV027, Fostamatinib
Study Phase: Phase 2/Phase 3
A Randomized, Controlled, Open-labeled, Multi-center Clinical Trial to Evaluate the Safe and Effective Performance of the Lungpacer Diaphragm Pacing Therapy System in Patients Who Have Failed to Wean From Mechanical Ventilation.
A Randomized, Controlled, Open-labeled, Multi-center Clinical Trial to Evaluate the Safe and Effective Performance of the Lungpacer Diaphragm Pacing Therapy System in Patients Who Have Failed to Wean From Mechanical Ventilation.
Enrollment Status: Terminated
Publish Date: December 09, 2024
Intervention Type: Device
Study Phase: Not Applicable
Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Effect of Anti-CD14 Treatment in Hospitalized Patients With COVID-19
Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Effect of Anti-CD14 Treatment in Hospitalized Patients With COVID-19
Enrollment Status: Terminated
Publish Date: June 26, 2023
Intervention Type: Other, Drug, Biological
Study Drugs: Anti-CD14, Remdesivir
Study Phase: Phase 2
Passive Immunity Trial for Our Nation (PassItOn)
Passive Immunity Trial for Our Nation (PassItOn)
Enrollment Status: Completed
Publish Date: November 03, 2022
Intervention Type: Biological
Study Drug: Anti-COVID-19 Plasma
Study Phase: Phase 3
A Prospective, Multi-Center, Randomized, Controlled, Pivotal Trial to Validate the Safety and Efficacy of the Hemolung® Respiratory Assist System for COPD Patients Experiencing an Acute Exacerbation Requiring Ventilatory Support
A Prospective, Multi-Center, Randomized, Controlled, Pivotal Trial to Validate the Safety and Efficacy of the Hemolung® Respiratory Assist System for COPD Patients Experiencing an Acute Exacerbation Requiring Ventilatory Support
Enrollment Status: Terminated
Publish Date: October 14, 2022
Intervention Type: Device
Study Phase: Not Applicable
Mesenchymal Stromal Cells for the Treatment of Moderate to Severe COVID-19 Acute Respiratory Distress Syndrome
Mesenchymal Stromal Cells for the Treatment of Moderate to Severe COVID-19 Acute Respiratory Distress Syndrome
Enrollment Status: Terminated
Publish Date: April 25, 2022
Intervention Type: Biological, Drug
Study Drug: Remestemcel-L
Study Phase: Phase 3
Severe ARDS: Generating Evidence. A U.S. Multicenter Observational Study.
Severe ARDS: Generating Evidence. A U.S. Multicenter Observational Study.
Enrollment Status: Completed
Publish Date: January 28, 2020
View 6 Less Clinical Trials

240 Total Publications

Effectiveness of 2024-2025 COVID-19 Vaccination Against COVID-19 Hospitalization and Severe In-Hospital Outcomes - IVY Network, 26 Hospitals, September 1, 2024-April 30, 2025.
Effectiveness of 2024-2025 COVID-19 Vaccination Against COVID-19 Hospitalization and Severe In-Hospital Outcomes - IVY Network, 26 Hospitals, September 1, 2024-April 30, 2025.
Journal: medRxiv : the preprint server for health sciences
Published: September 15, 2025
Similar Doctors
Experienced in Venous Thromboembolism (VTE)
Dr. Neha Solanki
Intensive Care Medicine
Experienced in Venous Thromboembolism (VTE)
Dr. Neha Solanki
Intensive Care Medicine

Cleveland Clinic

9500 Euclid Ave, 
Cleveland, OH 
 (0.1 miles away)
216-444-6503
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Neha Solanki is an Intensive Care Medicine provider in Cleveland, Ohio. Dr. Solanki is rated as an Advanced provider by MediFind in the treatment of Venous Thromboembolism (VTE). Her top areas of expertise are Asthma, Pneumonia, Lung Metastases, and Chronic Obstructive Pulmonary Disease (COPD).

Siddharth Dugar
Experienced in Venous Thromboembolism (VTE)
Dr. Siddharth Dugar
Intensive Care Medicine
Experienced in Venous Thromboembolism (VTE)
Dr. Siddharth Dugar
Intensive Care Medicine

Cleveland Clinic Main Campus

9500 Euclid Avenue, 
Cleveland, OH 
 (0.1 miles away)
216-444-2200
Languages Spoken:
English, Hindi
See accepted insurances

Siddharth Dugar is an Intensive Care Medicine provider in Cleveland, Ohio. Dr. Dugar is rated as an Advanced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Liver Failure, Venous Thromboembolism (VTE), Urea Cycle Disorders (UCD), Heart Failure with Preserved Ejection Fraction (HFpEF), and Endoscopy.

Experienced in Venous Thromboembolism (VTE)
Dr. Sameer Avasarala
Intensive Care Medicine
Experienced in Venous Thromboembolism (VTE)
Dr. Sameer Avasarala
Intensive Care Medicine

University Hospitals

11100 Euclid Ave, 
Cleveland, OH 
 (0.9 miles away)
216-844-1000
Languages Spoken:
English
See accepted insurances

Sameer Avasarala is an Intensive Care Medicine provider in Cleveland, Ohio. Dr. Avasarala is rated as an Advanced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Lung Nodules, Lymphofollicular Hyperplasia, Pleural Effusion, Advanced Bronchoscopy, and Endoscopy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Duggal's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile